Get comprehensive solutions for Drug Facility Registration, NDC Registration, Drug Facility Renewal, Drug Label Compliance, Drug Facts Panel, and Drug Development Cycle such as business planning, product development, and preparing compliant draft labels. Our US compliance experts can help you get an NDC number and sell your OTC drug products in the USA.
Navigating the labeling requirements for over-the-counter (OTC) products can be difficult and confusing. This page provides a clear overview of what is needed to comply with regulations, including information on the types of ingredients that must be declared and how they should be displayed on labels. Our regulatory specialists will also help you with the eCTD requirements and submitting your application.
At Quality Smart Solutions, we have the capability to offer assistance in all phases of the drug development and marketing process, including product development, facility registration, business planning, USA drug label compliance, and more.
Alain Ménard, President & Co-founder of Green Beaver Company, shares his experience how QSS supported them in achieving FDA Drug Compliance Registration approval.
If you are looking for help with you FDA Drug Compliance, book a free consultation with our regulatory expert today.
OTC Drug Monograph Application and the OTC New Drug Application (NDA) are the two processes through which every OTC Drug manufacturer or packager has to market drugs in the US market.
Whether you’re a domestic or foreign manufacturer or importer of OTC Drugs, you need to show evidence that you meet GMP requirements.
We'll prepare your application for establishment registration on behalf of your firm and submit it to FDA through the applicable ESG gateway.
Drug categories include Over-the-Counter (OTC), prescription medications, radiopharmaceuticals, biologics, and gene therapies. OTC medications, often known as non-prescription pharmaceuticals, are health products offered in the United States that may be purchased without a medical prescription. These medications are both safe and effective in limited quantities and can be sold freely on store shelves.
In the United States, the FDA performs a regulatory evaluation of over-the-counter pharmaceuticals based on active pharmaceutical ingredients and labeling rather than evaluating specific drug formulations. In the United States, there are about 300,000 OTC medications on the market.
All over-the-counter (OTC) products must contain warnings and directions for use, both of which are dependent on the product’s active ingredients. Warnings required for OTC topical medications include skin irritation and hazards associated with the administered substance. Directions should outline how to properly administer the medication along with checklists of do’s and don’ts. It is important that consumers read these labels carefully before using any OTC product.
All OTC products must include a list of ingredients on their labels. This information helps consumers understand what substances are contained in the product and allows them to avoid ingredients they may be allergic to. Allergy information improves safety when using OTC products as individuals can identify any potential risks before applying the medication or ingesting it orally. Additionally, product formulation must also include proper dosing instructions for each individual ingredient used in the product.
Information related to the manufacturer and storage of OTC products must be included in the product label. Depending on where a product is manufactured or stored, there may be additional responsibilities that manufacturers are required to adhere to. Additionally, if OTC products are shipped bulk-packed, shippers must adhere to specific regulations and follow state, local, and federal laws pertaining to all materials being shipped.
Manufacturers of OTC products should include clear and accurate information that is relevant to the product on their labels or in the package. This may include expiration date, warnings, product specific directions, usage directions, entity responsible for testing the product and any other applicable regulatory information. All of this information should be clearly specified on the label or package to ensure that users are aware of all safety and usage instructions pertaining to the OTC product they are using.
Primary display panel requirements for OTC products require that all ingredient names, consonant with good manufacturing standards, must be disclosed. This includes active ingredients as well as inactive or “other” ingredients, including colors and fragrances. Additionally, the required information from the panel must be in reverse type order, with the most prominent product name listed first followed by the active ingredients and dosage directions.
Domestic and foreign establishments that manufacture, repack, or re-label drug products in the United States are required to register with the FDA. Domestic and foreign drug manufacturers, repackers or re-labelers are also required to list all of their commercially marketed drug products.
Domestic and foreign establishments that manufacture, repack, or re-label drug products in the United States are required to register with the FDA. Domestic and foreign drug manufacturers, repackers or re-labelers are also required to list all of their commercially marketed drug products. FDA regulations work to make sure that OTC drugs are safe and that the labels are easy for consumers to understand. All OTC drugs must meet FDA quality, safety and effectiveness standards. To learn more about these standards message us at info@qualitysmartsolutions.com
To register or list your OTC drugs products, you’ll need to complete an establishment registration and file the appropriate drug listing information through the FDA’s online portal. If you need help with importing OTC drugs products you can email us for more information at info@qualitysmartsolutions.com.
OTC drugs that are sold in the U.S need to be labelled with a National Drug Code (NDC) which shows that the medicine has satisfied all safety, quality and efficacy standards. There are regulatory pathway requirements that include two processes every OTC drug manufacturer and packager must follow in the US market. These include the OTC Drug Monograph Application and the OTC New Drug Application (NDA). You’ll be required to show evidence that you meet GMP requirements as well if you are an importer of OTC drugs. You’ll also be required to obtain an Establishment Licence for manufacturing, selling or importing non-prescription drugs in the U.S.
You have a protein product ready to bring to market in Canada, and classifying it correctly is holding up your launch. The line that protein
... Read moreIf you are bringing medical devices to the Canadian market, one of the first compliance questions to resolve is whether you need a medical device
... Read moreAs of January 2026, Health Canada’s Regulatory Enrolment Process (REP) is mandatory for all Class II, III, and IV medical device licence (MDL) applications. This change, signalled since
... Read moreHealth Canada issued updated versions of both its Primary Sunscreen Monograph and Secondary Sunscreen Monograph on December 19, 2025, replacing the versions that had been in place
... Read morePlease complete the form below. We will respond to you soon.
